Remember when Generic Drugs where to save medication costs? Well, Pharma has taken the term, and jacked the prices up! The Great Generic Drug Rip-Off (December 16, 2014) Big Pharma has followed the only avenue left to reap billion-dollar… Continue Reading
Novartis AG (NVS) Researchers Claim to Have Discovered “Fountain of Youth” Drug Tongue in cheek I have to say that I hope I live so long to see this. December 29, 2014 By Mark Terry, BioSpace.com Breaking News Staff Researchers with… Continue Reading
Pharma Firms Have Plenty of Ammo for Another Big M&A Year in 2015 More healthcare mergers ahead? The sector certainly has the balance sheet for it. Cash reserves at pharmaceutical companies jumped 11% year over year in the third quarter… Continue Reading
This is certainly an all inclusive list of high flyers in the Big Pharma game – notice the exclusion of Gilead – but, will give you an idea of who is doing what, and the results. Johnson&Johnson, already the world’s… Continue Reading
Once again – TedTalks – provides amazing insights into the future of all things, and in this case – Medicine. Medicine, and the practice of it, will change dramatically in the next decade. Just as in the case of a… Continue Reading
The 10 Largest Pharmaceutical Companies In the World By Isabel Rollandi in Lists Published: December 20, 2014 at 6:26 am Wondering which are the largest pharmaceutical companies in the world? The collective biotech and pharmaceutical industry is known to be… Continue Reading
Drug Price War Takes Pharma Back To The Future – Matthew Herper Forbes Staff For biotech investors, the news that AbbVie ABBV -1.09% has cut a deal with Express Scripts ESRX +1.7% to sell its new hepatitis C treatment, the… Continue Reading
I have worked for both of the leaders in MDx. I was at Abbott, as a Strategy Manager for Europe, Middle-East, and Africa. I was based in Wiesbaben-Delkenheim. I do speak fluent German. Principal to that was launching the cash… Continue Reading
Firstly, I (we) do not work for Business week, but act as Global Consultants. We thought we would share… The links, that you follow, at Bloomberg, are not our responsility. We remain in the Biotech / Life Science arena. But,… Continue Reading
The lawyers for the Southeastern Pennsylvania Transportation Authority, or SEPTA, announced on Wednesday that they have filed a lawsuit against Gilead Sciences challenging the “exorbitant pricing” of its hepatitis C drug, Sovaldi. The release from Philadelphia’s transit agency said that… Continue Reading
Giant Merck Buying Lexington’s (MA) Cubist Cubist, founded in 1992, has become the world’s leading antibiotics developer at a time when many larger companies have scaled back research and development in the field. Cubist Pharmaceuticals spent $300 million on antibiotic… Continue Reading
Disrupting Cancer from CBS 60 Minutes I’d already wrtiiten about futuristic ideas, and mobile devices, here. Already, this video has stirred both commentary, and crticism from Forbes Magazine, that great source of medical information: Patrick Soon-Shiong, the richest doctor in… Continue Reading
Last month in Silicon Valley, biologists Jennifer Doudna and Emmanuelle Charpentier showed up in black gowns to receive the $3 million Breakthrough Prize, a glitzy award put on by Internet billionaires including Mark Zuckerberg. They’d won for developing CRISPR-Cas9, a… Continue Reading
Here is another brilliant TEDTalk – Ideas Worth Spreading. What Veterinarians Know That Doctors Don’t. Spoiler Alert: What do you call a Veterinarian, who can only take care of one species? A Physician. Barbara Natterson-Horowitz Barbara Natterson-Horowitz, Professor of Medicine… Continue Reading
FierceBiotech is the drug development industry’s news monitor, covering biopharma deals, clinical trials, FDA decisions, and more. Subscribe to our free daily email and join the largest, most influential biotechnology news audience in the world. Sign up today! FierceBiotech is… Continue Reading
Biosimilars: A Global Perspective of a New Market Opportunities, Threats and Critical Strategies 2014 It’s rare to see the emergence of an entirely new business segment, but that’s what’s happened in the drug development industry with biosimilars — similar versions… Continue Reading
Pharmaceuticals industry facing fundamental change By Richard Anderson Business reporter, BBC News Continue reading the main story Related Stories Pharma industry gets high on profits Drugs fund ‘papers over cracks’ The frantic race for an Ebola vaccine Watch Pharmaceuticals is… Continue Reading
Cancer, insidious, family / personal wrecking. No one wants that report. Things are moving forward. And, that work all too often comes from brilliant minds from outside the US of A. We deal with greater minds in the field of… Continue Reading